| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.1 | 0.7 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |